Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-10-03
2006-10-03
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S274000, C544S296000, C544S310000, C544S311000
Reexamination Certificate
active
07115616
ABSTRACT:
Pyrimidinone compounds of formula (10 are inhibitors of the enzyme Lp-PLA2and of use in therapy, in particular for treating atherosclerosis.
REFERENCES:
patent: 6953803 (2005-10-01), Hickey et al.
patent: 1 582 527 (1981-01-01), None
patent: WO 99/24420 (1999-05-01), None
patent: WO 00/10980 (2000-03-01), None
Fenwick Ashley Edward
Hickey Deirdre Mary Bernadette
Ife Robert John
Leach Colin Andrew
Pinto Ivan Leo
Kanagy James M.
Kifle Bruck
Kinzig Charles M.
SmithKline Beecham Plc
Venetianer Stephen
LandOfFree
Pyrimidinone compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrimidinone compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidinone compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3646416